Treatment of patients with amiodarone-induced thyrotoxicosis type 2.

Recruiting

• Registration Number: NL-OMON22747

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

TSH <0.4 mE/L, FT4 >25 pmol/l, normal or raised T3 , thyroid peroxidase antibodies <50 kU/l, TBII < 2.0 kU/l, amiodarone use, poor or no visualisation of thyroid gland on 99mTc-pertechnetate scintigraphy, no nodular goiter on ultrasound.

Exclusion Criteria

Very critical illness, drug or alcohol abuse, pregnancy, no informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Achievement of euthyroidism (TSH >0.4 mE/L at 3 and 6 months.

Secondary Outcome Measures

Name	Time	Method
Development side-effects.